• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

125.3900 USD 0.8500 0.67%

As of 20:04:04 ET on 04/17/2014.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 126.0000 High - Low: 128.8100 - 123.7752 Primary Exchange: NYSE Arca
Volume: 859,006 52-Week Range: 99.1352 - 172.5240 Beta vs SPSIBITR: 1.0009

ETF Chart for XBI

No chart data available.
  • XBI:US 125.3900
  • 1D
  • 1M
  • 1Y
126.2400
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2014-04-17) 125.5009
Assets (M) (on 2014-04-17) 1,104.4080
Shares out (M) 8.80
Market Cap (M) 1,103.43
% Premium -0.09
Average 52-Week % Premium -0.0141
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-03-21) 0.3330
Dividend Yield (ttm) 0.41%

Performance for XBI

1-Month -20.09% 1-Year +23.16%
3-Month -19.79% 3-Year +20.86%
Year To Date -3.48% 5-Year +22.76%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 04/17/2014
Name Position Value % of Total
MannKind Corp 3,025,583 18,909,894 1.713%
Myriad Genetics Inc 486,554 18,474,455 1.674%
Geron Corp 9,308,122 18,057,757 1.636%
Repligen Corp 1,137,155 18,012,535 1.632%
United Therapeutics Corp 179,420 17,260,204 1.564%
Exact Sciences Corp 1,300,335 16,696,301 1.512%
Alkermes PLC 374,586 16,526,734 1.497%
Arena Pharmaceuticals Inc 2,624,635 16,220,244 1.469%
Celgene Corp 114,002 16,132,423 1.461%
Amgen Inc 138,982 16,046,862 1.454%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil